Metabolic brain disease

Gene and cell therapies for treating Alzheimer's disease

Updated

Abstract

Alzheimer's disease (AD) is the top cause of dementia and may be treated with innovative cell and gene therapies.

  • AD is characterized by amyloid plaques and neurofibrillary tangles in the brain.
  • Current treatments mainly alleviate symptoms without stopping disease progression.
  • Three cholinesterase inhibitors and memantine are available for improving cognitive function.
  • Gene therapy could enhance neuroprotective factors and reduce amyloid plaque buildup.
  • Cell-based therapies may help replace lost neurons and restore neural function.
  • New treatment strategies offer hope for better patient outcomes and quality of life.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free